Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : GOPwinger Lies/Distortions/Omissions/Perversions of Truth -- Ignore unavailable to you. Want to Upgrade?

To: SeachRE who wrote (51710)	7/6/2005 8:15:05 AM
From: jttmab	Read Replies (1) \| Respond to of 173976

Finding palliatives are hard enough. Imagine cures??? Sure I can imagine cures. Anti-biotics are cures. Vaccines certainly aren't palliatives. I agree they aren't cures. Lotsa new antibiotics and vaccines coming along. Simply not true. Major drug companies are pulling out of antibiotic development - and their timing couldn't be worse, a leading meeting on infectious disease was told this week. Speakers at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago said that many firms, such as Roche and Eli Lilly, are turning away from antibiotics to concentrate on treatments for chronic illness instead. Yet the need for new drugs has never been greater. Resistance to antibiotics is growing - 20% of infections in US hospitals involve multidrug-resistant bacteria, reports the Food and Drug Administration (FDA). Moreover, the pipeline of new antibiotics is running dry: the FDA has approved just two this year. "There's unequivocal evidence that antimicrobial research is on a steep downward slope," said John Edwards, head of policy at the Infectious Diseases Society of America. Recent scares over diseases such as anthrax have served as a reminder that it is impossible to predict when new anti- infectious agents will be needed. The retreat was palpable at the meeting. There were 10% fewer presentations of new drug candidates than last year, and a slump in attendees from industry. "Attendance is down, the number of new antimicrobial agents is down," said Barbara Murray of the University of Texas Medical School in Houston, chair of the meeting's programme committee.... bioedonline.org Some drug companies are in the "broken bone business" offering plates, rods and bone filling. Being in the broken bone business is substantially different than curing broken bones. The US system is more demanding of Quality. It's a matter of survival of the fittest(it's not perfect!). Another unsupported claim. The FDA doesn't even make that claim. All the FDA has said, effectively, is they don't know [because they haven't looked.]. But when the US was short on flu vaccine they looked to Canada and bought some. How many US citizens are flying to Canada to solve serious medical problems? What about the reverse? I don't know and neither do you. And what does that have to do with pharms anyway? If you wanted to stay on topic. You would have asked how many Americans cross the Canadian border for drugs and vice versa? I've never heard of a case where a Canadian has crossed the border to obtain drugs. Have you? As for link, Google it. You make claims and I have to do the research to support it/or disprove it? I'll bet you can make unsupported claims faster than I can research them. jttmab